Comprehensive Epigenomic Profiling from Plasma to Inform Drug Development & Patient Selection in Oncology and Non-oncology
Time: 2:20 pm
day: Day Two Track B
Details:
- Liquid biopsies are highly valuable assays for cancer diagnostic and treatment but going beyond genomics is key
- Epigenomics measures dynamic gene expression changes in cancers that can yield novel insights into cancer biology, pathways and targets
- Precede has developed an epigenomics profiling method of cancer from 1 ml plasma providing a genomic wide measurement of promoters and enhancers activation as well as methylation
